热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse CD117 (c-Kit) Antibody
产品名称：
PE/Cyanine7 anti-mouse CD117 (c-Kit) Antibody
产品类别：
抗体
产品编号：
105813
产品应用：
105813
[价格]
规格 价格 库存
25µg ￥ 1044 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse bone marrow mast cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry of acetone fixed frozen sections2, and spatial biology (IBEX)5,6. The 2B8 antibody does not block c-Kit activity.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Ikuta K, et al. 1992. P. Natl. Acad. Sci. USA 89:1502. (FC)
  2. Podd BS, et al. 2006. J. Immunol. 176:6532. PubMed (IHC)
  3. Bachelet I, et al. 2008. J. Immunol. 180:6064. PubMed (FC)
  4. Charles N, et al. 2010. Nat. Med. 16:701. PubMed (FC)
  5. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  6. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  2. Soukup AA, et al. 2019. J Clin Invest. 129:1180. PubMed
  3. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  4. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  5. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  6. Shiozawa Y, et al. 2010. PLoS One. 5:e10853. PubMed
  7. Ray S, et al. 2020. J Biol Chem. 295:7113. PubMed
  8. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  9. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  10. Minutti CM, et al. 2019. Immunity. 50:645. PubMed
  11. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  12. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  13. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  14. Thomas GE, et al. 2022. Nat Cell Biol. 24:872. PubMed
  15. Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed
  16. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  17. Dráberová L, et al. 2020. Front Immunol. 10:3068. PubMed
  18. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  19. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  20. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  21. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  22. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  23. Sochalska M, et al. 2016. Oncogene. 10.1038/onc.2016.362. PubMed
  24. Nakano N, et al. 2008. J Allergy Clin Immunol. 123:74. PubMed
  25. Simon M, et al. 2019. Cell Metab. 29:871. PubMed
  26. De S, et al. 2018. Development. 145. PubMed
  27. Nakagawa T, et al. 2021. Cell Rep. 37:109875. PubMed
  28. Mantri CK, et al. 2019. J Clin Invest. 129:1094. PubMed
  29. Chen I, et al. 2016. Sci Rep. 6:27195. PubMed
  30. Obata-Ninomiya K, et al. 2013. J Exp Med. 210:2583. PubMed
  31. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  32. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  33. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  34. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  35. Tavakol DN, et al. 2021. Curr Protoc. 1:e275. PubMed
  36. Shen YC, et al. 2021. Nat Commun. 12:3876. PubMed
  37. Seneviratne AK, et al. 2019. Cell Stem Cell. 24:621. PubMed
  38. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  39. Shibata F, et al. 2009. Stem Cells. 27:183. PubMed
  40. Pierce H, et al. 2017. Cell Stem Cell. 1.283333333. PubMed
  41. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  42. Pinho S et al. 2018. Developmental cell. 44(5):634-641 . PubMed
  43. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  44. Mehta C, et al. 2021. Nucleic Acids Res. 49:9007. PubMed
  45. Wei Q, et al. 2020. Dev Cell. 53:503. PubMed
  46. Roussel M, et al. 2021. Cell Reports Medicine. 2(6):100291. PubMed
  47. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  48. Zheng X, et al. 2015. Cell Rep. 13:1505-1518. PubMed
  49. Kanemaru K, et al. 2015. PLoS One. 10: 0144436. PubMed
  50. Joseph J, et al. 2012. Mol Cancer Res. 0.681944444. PubMed
  51. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  52. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  53. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  54. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  55. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  56. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  57. Sulsenti R, et al. 2021. Frontiers in Immunology. 12:622001. PubMed
  58. Xu H, et al. 2012. Blood. 120:3089. PubMed
  59. Tung LT, et al. 2021. Cell Death Dis. 12:923. PubMed
  60. Soukup AA, et al. 2021. Sci Adv. 7:eabk3521. PubMed
  61. Gao X, et al. 2021. Nature. 589:591. PubMed
  62. Yao Z, et al. 2020. Cancer Res. 80:1171. PubMed
  63. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  64. Mesa-Nu?ez C, et al. 2022. Mol Ther Methods Clin Dev. 26:459. PubMed
  65. Wilkinson AC, et al. 2019. Nature. 571:117. PubMed
  66. Vannini N, et al. 2016. Nat Commun. 7:13125. PubMed
  67. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  68. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  69. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  70. Gawish R, et al. 2022. Elife. 11:. PubMed
RRID
AB_313222 (BioLegend Cat. No. 105813) AB_313223 (BioLegend Cat. No. 105814)

Antigen Details

Structure
Ig superfamily, 145 kD
Distribution

Hematopoietic stem cells, AML, mast cells

Function
Growth factor receptor, tyrosine kinase
Ligand/Receptor
Stem Cell Factor (SCF)
Cell Type
Embryonic Stem Cells, Hematopoietic stem and progenitors, Leukemia, Mast cells, Mesenchymal Stem Cells
Biology Area
Immunology, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Galli SJ, et al. 1994. Adv. Immunol. 55:1.
3. Ikuta K, et al. 1992. Annu. Rev. Immunol. 10:759.
4. Besmer P, et al. 1986. Nature 320:415.
5. Witte ON. 1990. Cell 63:5.

Gene ID
16590 View all products for this Gene ID
UniProt
View information about CD117 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线